Company intelligence / Profile preview

CROSS Research

Ownership: Private
Development stage: Commercial

Overview

CROSS Research is a licensed Contract Research Organization focused on conducting Phase I clinical trials in healthy volunteers and special populations. Their expertise includes safety studies, pharmacokinetics, bioavailability/bioequivalence assessments, drug-drug interaction studies, and specialized evaluations such as skin adhesiveness for patches and medical device testing. They offer strategic laboratory collaborations to support comprehensive early-stage drug development.

Modalities: Small moleculeBiologicMedical deviceNutraceuticals
Industry: Contract Research Organization

Partnerships

CROss Alliance® (strategic collaboration with centralized labs and analytical/pharmaceutical labs)

Beyond the preview

Go deeper on CROSS Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CROSS Research.

Explore the full profile